کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5667415 | 1592042 | 2016 | 6 صفحه PDF | دانلود رایگان |

- Serum alanine aminotransferase (ALT) is a controversial marker for monitoring disease in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients.
- A significant proportion of HBeAg-negative hepatitis B virus (HBV)-infected patients with high HBV DNA levels may have significant histological liver abnormalities despite persistently normal ALT.
- Age and HBV DNA viral load were independent predictors of significant liver damage in HBeAg-negative CHB patients with persistently normal ALT.
SummaryObjectivesSerum alanine aminotransferase (ALT) is a controversial marker for disease monitoring in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. The aim of this study was to determine the fibrosis stage and histological activity index (HAI) in HBeAg-negative CHB patients with persistently normal ALT (PNALT) and high serum HBV DNA (â¥2000 IU/ml) and to investigate clinical risk factors for the requirement of treatment through the examination of liver biopsy specimens.MethodsHBeAg-negative CHB patients with PNALT (â¤40 IU/l) and high serum HBV DNA (â¥2000 IU/ml) were included. HBV fibrosis stage and HAI were scored according to the Ishak system. Multivariate logistic regression analysis was used to estimate the independent risk factors for fibrosis stage â¥2 and/or HAI â¥6. Receiver operating characteristic curve analysis was used to determine an optimal age cut-off for liver biopsy.ResultsA total 120 patients were enrolled. These patients had a mean HBV DNA level of 123 680 ± 494 500 IU/ml; the HBV DNA load was 2000-20 000 IU/ml in 68 patients (56.6%) and â¥20 000 IU/ml in 52 (43.4%). Eighteen patients (15%) had moderate-to-severe histological activity (HAI â¥6). Forty-three patients (35.9%) had a fibrosis stage â¥2. Forty-eight patients (40%) had a fibrosis stage â¥2 and/or HAI â¥6. On multivariate logistic regression analysis, independent variables associated with fibrosis stage â¥2 and/or HAI â¥6 included age and HBV DNA viral load. Patients with HBV DNA 2000-20 000 IU/ml were more likely to require treatment compared to those with a viral load â¥20 000 IU/ml. The optimal age cut-off to predict fibrosis stage â¥2 and/or HAI â¥6 was 46 years.ConclusionsSignificant liver damage was detected in 40% of CHB patients with PNALT and high HBV DNA upon biopsy. Age and HBV DNA viral load were independent predictors of significant liver damage. A biopsy to determine the degree of liver damage is advisable for CHB patients older than 46 years.
Journal: International Journal of Infectious Diseases - Volume 52, November 2016, Pages 68-73